| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $103.54B | $54.01B | $145.23B |
| YoY Revenue Growth % | +91.7% | -62.8% | — |
| Gross Profit | $44.4M | -$4.2M | — |
| Gross Margin % | 0.0% | 0.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$4.5M | -$52.0M | -$8.3M |
| Operating Margin % | 0.0% | -0.1% | 0.0% |
| Net Income (GAAP) | -$1.9M | -$62.7M | -$984.0K |
| EBITDA (Normalized) | -$4.0M | -$51.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $10.3M | -$12.4M | -$37.2M |
| Capital Expenditures (CapEx) | $642.0K | $1.3M | — |
| Free Cash Flow (FCF) | $9.7M | -$13.6M | -$37.2M |
| FCF Margin % | 0.0% | 0.0% | 0.0% |
| Return on Invested Capital (ROIC %) | -17.8% | -45.0% | — |
| Cash & Short-Term Equivalents | $7.7M | $11.7M | — |
| Total Debt (Short + Long Term) | $0 | $40.5M | — |
| Total Stockholders' Equity | $27.6M | $8.4M | — |